CD7 and leukemia: Multiple subclones were found in 2/3 samples unequally distributed within the CD7+/CD34+ and CD7+/CD34− fractions, and their respective frequencies as well as oncogenic events seem to play roles in the specific abilities of CD34+/− cells to perpetrate leukemia in xenograft models.